Pharma-Bio Serv, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $13.3M |
| Cost of Revenue | $9.5M |
| Gross Profit | $3.8M |
| Gross Margin | 28.9% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $4.7M |
| Operating Income | $-777.8K |
| Operating Margin | -5.8% |
| Interest Expense | — |
| Pretax Income | $-774.0K |
| Income Tax Expense | $3.9K |
| Net Income | $-1.4M |
| Net Margin | -10.6% |
| EPS (Basic) | $-0.06 |
| EPS (Diluted) | $-0.06 |
| Shares Outstanding (Basic) | 23.1M |
| Shares Outstanding (Diluted) | 23.1M |
| Dividends Per Share | — |